1 00:00:00,160 --> 00:00:04,960 Speaker 1: This episode contains distressing themes, including suicide and disordered eating. 2 00:00:05,360 --> 00:00:08,080 Speaker 1: For twenty four to seven support, please contact Lifeline on 3 00:00:08,200 --> 00:00:12,040 Speaker 1: thirteen eleven fourteen. You'll find some links to more resources 4 00:00:12,080 --> 00:00:13,880 Speaker 1: in today's episode description. 5 00:00:16,480 --> 00:00:20,880 Speaker 2: Welcome to the eighty second Golden Gloves, o Zembich's Biggest Night. 6 00:00:21,400 --> 00:00:24,560 Speaker 1: From viral weight loss drug to Hollywood punchline. 7 00:00:24,600 --> 00:00:27,720 Speaker 3: What don't we think of this ozembic takeover in Hollywood? 8 00:00:28,280 --> 00:00:30,720 Speaker 3: Excuse me no beg. 9 00:00:31,720 --> 00:00:34,879 Speaker 1: Once lauded as the silver bullet to the stars, Ozempic 10 00:00:35,040 --> 00:00:36,919 Speaker 1: and other similar medications have. 11 00:00:37,000 --> 00:00:39,080 Speaker 3: Slowly but surely crossed. 12 00:00:38,680 --> 00:00:44,040 Speaker 1: Into the mainstream, bringing with them new conversations about body image, ethics, 13 00:00:44,320 --> 00:00:46,200 Speaker 1: health and accessibility. 14 00:00:46,479 --> 00:00:47,519 Speaker 4: There is so much demand. 15 00:00:48,040 --> 00:00:53,040 Speaker 5: There is demand for this that outstrips anything we've ever say. 16 00:00:53,200 --> 00:00:57,360 Speaker 1: But what does the exploding global popularity of ozepic mean 17 00:00:57,600 --> 00:00:58,480 Speaker 1: for young people? 18 00:00:58,920 --> 00:01:03,440 Speaker 6: Definitely a lot something new. I've never had disordered eating, 19 00:01:03,600 --> 00:01:05,800 Speaker 6: despite being a little bit bigger kind of growing up 20 00:01:05,880 --> 00:01:08,360 Speaker 6: my whole life, I was comfortable and like confident in 21 00:01:08,400 --> 00:01:11,479 Speaker 6: who I was and everything, and yeah, it could really 22 00:01:11,520 --> 00:01:12,960 Speaker 6: be further from that now. 23 00:01:13,400 --> 00:01:17,959 Speaker 1: On the first episode of Investigating Ozenpic, we explored the 24 00:01:18,080 --> 00:01:22,080 Speaker 1: new world of weight loss drugs GLP ones like ozeen, pic, 25 00:01:22,280 --> 00:01:25,839 Speaker 1: we go v, and Munjaro to understand how they work, 26 00:01:26,080 --> 00:01:29,520 Speaker 1: what they cost, and the many and varied side effects 27 00:01:29,600 --> 00:01:33,600 Speaker 1: associated with their use. This time we'll dive deeper into 28 00:01:33,640 --> 00:01:38,560 Speaker 1: how these medications are being prescribed, their accessibility, and the 29 00:01:38,600 --> 00:01:41,319 Speaker 1: world of online and telehealth providers. 30 00:01:41,720 --> 00:01:44,520 Speaker 2: It's tempting to say the solution is get rid of 31 00:01:44,600 --> 00:01:48,920 Speaker 2: these telehealth companies. That's not the solution. Our regular gps 32 00:01:49,000 --> 00:01:51,720 Speaker 2: need to do better about weight because so many people 33 00:01:51,920 --> 00:01:55,160 Speaker 2: are scared of going to the doctor because they're going 34 00:01:55,200 --> 00:01:57,880 Speaker 2: to get picked on about their weight from. 35 00:01:57,640 --> 00:01:58,480 Speaker 3: The daily os. 36 00:01:58,640 --> 00:02:07,040 Speaker 1: I'm Emma Gillespie and this is Investigating Ozmpic, Part two. 37 00:02:12,240 --> 00:02:16,240 Speaker 1: On episode one of Investigating Ozempick, we met McKenzie, the 38 00:02:16,280 --> 00:02:18,800 Speaker 1: twenty six year old woman who sought out Ozenpick for 39 00:02:18,840 --> 00:02:23,000 Speaker 1: weight management, only to end up in hospital weeks later. I, for. 40 00:02:23,000 --> 00:02:25,240 Speaker 7: No reason whatsoever, and I hadn't felt like this for 41 00:02:25,280 --> 00:02:29,000 Speaker 7: a very long time, became suicidal unable to work. 42 00:02:29,480 --> 00:02:32,840 Speaker 1: Mackenzie told us she was prescribed Ozempick via an online 43 00:02:32,880 --> 00:02:34,359 Speaker 1: provider called Juniper. 44 00:02:35,000 --> 00:02:38,440 Speaker 2: When we think of weight loss, calorie counting, intensive exercise, 45 00:02:38,560 --> 00:02:41,840 Speaker 2: but science suggests they're not a sure way to achieving 46 00:02:41,960 --> 00:02:44,600 Speaker 2: long term weight loss? How can Juniper help. 47 00:02:44,560 --> 00:02:47,720 Speaker 4: Women following the Juniper program can lose over eleven percent 48 00:02:47,880 --> 00:02:50,560 Speaker 4: of their body weight in just seven months. Wow. Juniper's 49 00:02:50,560 --> 00:02:53,160 Speaker 4: medical weight loss program includes a treatment that works to 50 00:02:53,200 --> 00:02:57,000 Speaker 4: suppress appetite, overhaul hunger signals, and ultimately help us feel 51 00:02:56,960 --> 00:02:57,680 Speaker 4: fuller for longer. 52 00:03:00,120 --> 00:03:03,160 Speaker 1: While Juniper is the focus of this episode, it's worth 53 00:03:03,240 --> 00:03:06,360 Speaker 1: noting that it's not the only virtual health provider that 54 00:03:06,480 --> 00:03:12,560 Speaker 1: prescribes weight loss medications in Australia. Other popular platforms include mosh, Instance, 55 00:03:12,600 --> 00:03:17,440 Speaker 1: Scripts and Yulie. But during our investigations for this series, 56 00:03:17,639 --> 00:03:21,920 Speaker 1: TDA conducted various callouts and audience polls, from which we 57 00:03:22,040 --> 00:03:26,480 Speaker 1: received a large volume of responses. A clear pattern emerged 58 00:03:26,520 --> 00:03:29,920 Speaker 1: amongst that feedback, which put Juniper in a category of 59 00:03:29,960 --> 00:03:35,080 Speaker 1: its own. For example, TDA didn't ask participants to name providers, 60 00:03:35,280 --> 00:03:38,560 Speaker 1: but in open prompts, Juniper accounted for an average of 61 00:03:38,640 --> 00:03:43,960 Speaker 1: seventy six percent of provider mentions. TDA does acknowledge though 62 00:03:44,160 --> 00:03:47,040 Speaker 1: some of the issues and prescribing practices were going to 63 00:03:47,120 --> 00:03:53,280 Speaker 1: discuss may be common to other platforms. The provider describes 64 00:03:53,320 --> 00:03:57,800 Speaker 1: itself as leading the way in medical weight loss, promising customers, 65 00:03:57,960 --> 00:04:02,560 Speaker 1: specifically women, a whole balistic approach for lasting results with 66 00:04:02,720 --> 00:04:08,880 Speaker 1: dietitian led health coaching, educational resources, health tracking, and unlimited follow. 67 00:04:08,680 --> 00:04:11,000 Speaker 3: Ups for patients with their Juniper doctor. 68 00:04:11,520 --> 00:04:15,400 Speaker 1: The platform is part of an Aussie health startup called Eucalyptus. 69 00:04:15,760 --> 00:04:19,840 Speaker 1: The company, in which describes itself as a global telehealth provider, 70 00:04:20,200 --> 00:04:25,000 Speaker 1: also runs Dermatology brand Software, Fertility Health Service Kin and 71 00:04:25,240 --> 00:04:30,360 Speaker 1: two men's health clinics, Pilot and Compound. Today it employs 72 00:04:30,560 --> 00:04:32,480 Speaker 1: hundreds of people around the world. 73 00:04:32,680 --> 00:04:36,400 Speaker 7: Chronic conditions are responsible for seventy five percent of all deaths. 74 00:04:37,000 --> 00:04:39,720 Speaker 7: The economic strain on the system is a breaking point. 75 00:04:40,120 --> 00:04:43,120 Speaker 8: We need to keep people out of hospital, intercepting them 76 00:04:43,200 --> 00:04:47,360 Speaker 8: upstream from the traditional healthcare system. Eucalyptus is building the 77 00:04:47,400 --> 00:04:50,760 Speaker 8: future of the preventative healthcare system to meet good health 78 00:04:50,880 --> 00:04:51,799 Speaker 8: last a lifetime. 79 00:04:53,360 --> 00:04:57,560 Speaker 1: Patients across all five Eucalyptus brands can consult with registered 80 00:04:57,600 --> 00:05:02,919 Speaker 1: clinicians to access prescription medication and treatments. Scripts are issued 81 00:05:02,960 --> 00:05:07,880 Speaker 1: electronically and filled by Eucalyptus partner Pharmacies. The company says 82 00:05:07,960 --> 00:05:11,480 Speaker 1: harnessing the power of technology is at the center of 83 00:05:11,560 --> 00:05:15,760 Speaker 1: its mission. Here's Eucalyptus CEO Tim Doyle speaking about the 84 00:05:15,800 --> 00:05:18,640 Speaker 1: company in a twenty twenty three podcast interview. 85 00:05:19,200 --> 00:05:21,320 Speaker 5: The crust of the technology and a mission of Eucalyptus 86 00:05:21,440 --> 00:05:24,160 Speaker 5: is using technology to lower the cost of interaction with 87 00:05:24,200 --> 00:05:26,560 Speaker 5: the healthcare professional and then raising the quality of as introduction. 88 00:05:26,880 --> 00:05:31,159 Speaker 1: So is that what Eucalyptus has achieved with Juniper. To 89 00:05:31,320 --> 00:05:35,760 Speaker 1: understand more, we spoke to several Juniper patients. Many question 90 00:05:35,920 --> 00:05:39,560 Speaker 1: whether the platform is doing enough to prioritize patient care. 91 00:05:40,000 --> 00:05:44,120 Speaker 7: So you complete this online questionnaire essentially asking your medical history, etc. 92 00:05:44,760 --> 00:05:47,120 Speaker 7: And then they get back to you whe whether or 93 00:05:47,120 --> 00:05:50,200 Speaker 7: not you are suitable for the medication. A doctor reviews 94 00:05:50,240 --> 00:05:53,320 Speaker 7: your information and then says, yeah, we're happy to prescribe 95 00:05:53,320 --> 00:05:56,160 Speaker 7: you this. They've got a pharmacy dispature that they work with. 96 00:05:56,320 --> 00:05:57,040 Speaker 4: They sent it all that. 97 00:05:57,400 --> 00:06:01,400 Speaker 1: Mackenzie was prescribed as MPICK through June. Apart between the 98 00:06:01,480 --> 00:06:04,600 Speaker 1: questionnaire and receiving her first script, she said, the whole 99 00:06:04,640 --> 00:06:07,360 Speaker 1: process took only a couple of days. 100 00:06:07,160 --> 00:06:09,480 Speaker 7: And I never spoke to a doctor. They just reviewed 101 00:06:09,520 --> 00:06:12,240 Speaker 7: my information that I put in in a survey kind 102 00:06:12,240 --> 00:06:15,360 Speaker 7: of format. It did cover, you know, anything relevant to 103 00:06:15,360 --> 00:06:18,200 Speaker 7: my medical history, So, for example, any medications that I 104 00:06:18,279 --> 00:06:21,480 Speaker 7: was taking, history of mental health issues. Put that all 105 00:06:21,520 --> 00:06:21,880 Speaker 7: in there. 106 00:06:22,240 --> 00:06:26,040 Speaker 1: That included telling Juniper about an antidepressant she'd been taking 107 00:06:26,240 --> 00:06:27,560 Speaker 1: since her early teens. 108 00:06:27,839 --> 00:06:31,560 Speaker 7: I put very very clearly my exact medication, the dosage, 109 00:06:31,800 --> 00:06:34,880 Speaker 7: how long I've been diagnosed with major depressive disorder. I 110 00:06:35,040 --> 00:06:37,480 Speaker 7: was very very clear on all of that, and they 111 00:06:37,520 --> 00:06:40,159 Speaker 7: supposedly have a doctor reviewer and get back to you 112 00:06:40,240 --> 00:06:42,320 Speaker 7: and say, yeah, we're happy to authorize. 113 00:06:43,520 --> 00:06:46,560 Speaker 1: Within weeks, Mackenzie became suicidal. 114 00:06:47,000 --> 00:06:50,359 Speaker 7: It was largely really quite unexplained, and I was really 115 00:06:50,400 --> 00:06:51,320 Speaker 7: really concerned. 116 00:06:51,480 --> 00:06:55,080 Speaker 1: She'd initially decided not to go through her regular GP 117 00:06:55,279 --> 00:06:59,440 Speaker 1: for OZMPIC, but when her mood shifted, Mackenzie visited her 118 00:06:59,440 --> 00:07:02,520 Speaker 1: doctor in person. He told her there'd been a spike 119 00:07:02,560 --> 00:07:07,680 Speaker 1: in reports of suicidal ideation linked to OZEPIC. Mackenzie's GP 120 00:07:07,920 --> 00:07:12,040 Speaker 1: also explained that because the medication slows the digestive system, 121 00:07:12,280 --> 00:07:15,880 Speaker 1: it can negatively impact the way the body absorbs other medications, 122 00:07:16,400 --> 00:07:20,680 Speaker 1: reducing their effectiveness or in some cases, blocking them from 123 00:07:20,720 --> 00:07:21,720 Speaker 1: working at all. 124 00:07:21,960 --> 00:07:25,080 Speaker 7: It was incredibly scary because it was obviously depression, but 125 00:07:25,120 --> 00:07:28,080 Speaker 7: it was not depression I had felt before and the 126 00:07:28,120 --> 00:07:30,559 Speaker 7: doctor thinks that's because I was just so intensely coming 127 00:07:30,560 --> 00:07:33,200 Speaker 7: off in medication without being weaned off of it. 128 00:07:33,200 --> 00:07:35,720 Speaker 1: It was the first time the twenty six year old 129 00:07:35,720 --> 00:07:38,840 Speaker 1: had heard about the risk. Her doctor suggested she stopped 130 00:07:38,880 --> 00:07:43,160 Speaker 1: taking ozempic immediately, go to hospital and contact Juniper. 131 00:07:43,400 --> 00:07:46,120 Speaker 7: I essentially sent a message through and said, my doctors 132 00:07:46,160 --> 00:07:48,440 Speaker 7: advised me to stop taking this. These were the side effects, 133 00:07:48,440 --> 00:07:51,080 Speaker 7: et cetera. And the response was, well, that's not on 134 00:07:51,120 --> 00:07:54,160 Speaker 7: the listed side effects. It actually shouldn't affect your absorption 135 00:07:54,560 --> 00:07:55,000 Speaker 7: at all. 136 00:07:55,120 --> 00:07:59,200 Speaker 1: Mackenzie said she thoroughly interrogated all the information available to 137 00:07:59,240 --> 00:08:01,040 Speaker 1: her through resources. 138 00:08:01,280 --> 00:08:04,200 Speaker 7: No, I actually didn't say anything to do with mental health. 139 00:08:04,200 --> 00:08:07,160 Speaker 7: That wasn't mentioned on anything that consumers at least could 140 00:08:07,200 --> 00:08:10,200 Speaker 7: read that it would possibly reduce the absorption of medication 141 00:08:10,320 --> 00:08:13,080 Speaker 7: or anything like that. It did reduce the amount of 142 00:08:13,120 --> 00:08:15,720 Speaker 7: food noise, It did help me lose weight. But then 143 00:08:15,720 --> 00:08:18,280 Speaker 7: on the flip side, the side effects are so significant 144 00:08:18,280 --> 00:08:20,239 Speaker 7: that I would never do it again. 145 00:08:22,360 --> 00:08:25,280 Speaker 3: We'll be back with more of today's episode right after this. 146 00:08:26,600 --> 00:08:31,160 Speaker 1: Juniper disputes any relationship between these medications and an increased 147 00:08:31,240 --> 00:08:35,120 Speaker 1: risk of mental health related side effects. Its clinical director, 148 00:08:35,200 --> 00:08:38,960 Speaker 1: doctor Matt Vickers cited specific guidance from the UK Health 149 00:08:39,000 --> 00:08:42,920 Speaker 1: Regulator to TDA, which stated in September twenty twenty four 150 00:08:43,080 --> 00:08:46,840 Speaker 1: that the available data does not support a causal association 151 00:08:47,000 --> 00:08:52,760 Speaker 1: between GLP ones and suicide, suicidal ideation, self injury, and depression. 152 00:08:53,120 --> 00:08:56,440 Speaker 1: Vickers also pointed to similar findings detailed in a January 153 00:08:56,440 --> 00:08:59,720 Speaker 1: twenty twenty four update from the US Food and Drugg 154 00:08:59,720 --> 00:09:04,040 Speaker 1: Administration the FDA, which quote did not find an association 155 00:09:04,360 --> 00:09:08,640 Speaker 1: or clearly demonstrated relationship between GLP ones and the occurrence 156 00:09:08,720 --> 00:09:14,440 Speaker 1: of suicidal thoughts or actions. However, an analysis of adverse 157 00:09:14,480 --> 00:09:18,880 Speaker 1: reactions within the World Health Organization's Global database paints a 158 00:09:18,920 --> 00:09:23,440 Speaker 1: different picture. Findings from an international study published in August 159 00:09:23,559 --> 00:09:28,840 Speaker 1: twenty twenty four identified a quote disproportionate link between suicidal 160 00:09:28,880 --> 00:09:33,679 Speaker 1: ideation and semiglutyites, a type of GLP one. Considering this, 161 00:09:33,920 --> 00:09:37,600 Speaker 1: we took a closer look at the research cited by Juniper. 162 00:09:38,200 --> 00:09:41,200 Speaker 1: The data from the FDA, it quoted comes from the 163 00:09:41,240 --> 00:09:45,880 Speaker 1: preliminary evaluation of an ongoing study. Due to limitations in 164 00:09:45,920 --> 00:09:48,560 Speaker 1: the scope of reporting and research in this space, the 165 00:09:48,640 --> 00:09:52,559 Speaker 1: FDA conceded more clinical trials are needed and that a 166 00:09:52,640 --> 00:09:55,800 Speaker 1: quote cannot definitively rule out that a small risk of 167 00:09:55,840 --> 00:10:01,080 Speaker 1: suicidal ideation associated with GLP ones may exist. It said 168 00:10:01,160 --> 00:10:04,560 Speaker 1: it's continuing to look into the issue and will communicate 169 00:10:04,600 --> 00:10:09,760 Speaker 1: final conclusions and recommendations after it completes its review. Juniper 170 00:10:09,840 --> 00:10:12,559 Speaker 1: rejects claims it has failed in a duty of care 171 00:10:12,600 --> 00:10:16,480 Speaker 1: to patients and maintains there is no major known risk 172 00:10:16,559 --> 00:10:19,200 Speaker 1: of suicidal ideation as a side effect of the weight 173 00:10:19,200 --> 00:10:21,080 Speaker 1: loss medications it prescribes. 174 00:10:21,720 --> 00:10:23,839 Speaker 3: However, Vickers said we have. 175 00:10:23,920 --> 00:10:27,000 Speaker 9: One patients who have comorbid mental health conditions about the 176 00:10:27,040 --> 00:10:30,640 Speaker 9: possibility of low mood symptoms or deterioration, and to seek 177 00:10:30,640 --> 00:10:32,080 Speaker 9: support if they are concerned. 178 00:10:32,440 --> 00:10:36,160 Speaker 1: Juniper also says it has appointed several specialist staff with 179 00:10:36,360 --> 00:10:40,800 Speaker 1: mental health training and continues to screen patients extensively for 180 00:10:40,880 --> 00:10:45,920 Speaker 1: mental health conditions. Advice from the Therapeutic Goods Administration the 181 00:10:45,960 --> 00:10:50,520 Speaker 1: TGA for Munjarro notes the medication can impact the absorption 182 00:10:50,720 --> 00:10:56,240 Speaker 1: of certain other specific drugs, including the oral contraceptive pill, 183 00:10:56,280 --> 00:10:59,320 Speaker 1: but there is no advice cautioning the use of Munjarro 184 00:10:59,559 --> 00:11:01,559 Speaker 1: or we gow with antidepressants. 185 00:11:01,679 --> 00:11:04,360 Speaker 3: Juniper said it's unclear where that. 186 00:11:04,320 --> 00:11:09,320 Speaker 1: Leaves patients like McKenzie, who's lived experience with ozembic, contrasts 187 00:11:09,360 --> 00:11:14,319 Speaker 1: the clinical evidence in forming Juniper's current processes, processes which 188 00:11:14,520 --> 00:11:16,760 Speaker 1: she argues are not airtight. 189 00:11:17,120 --> 00:11:19,160 Speaker 7: I think it would be very easy to be dishonest 190 00:11:19,160 --> 00:11:21,480 Speaker 7: on they ask you your height and your weight and 191 00:11:21,520 --> 00:11:24,320 Speaker 7: do no kind of verification. And I mean, in my case, 192 00:11:24,360 --> 00:11:25,920 Speaker 7: I was telling the truth, but I think it would 193 00:11:26,000 --> 00:11:29,400 Speaker 7: be very easy to omit certain things or change certain 194 00:11:29,480 --> 00:11:32,560 Speaker 7: numbers without any kind of formal verification of that. 195 00:11:33,440 --> 00:11:36,840 Speaker 1: Juniper now requires users to upload photos of themselves, and 196 00:11:36,880 --> 00:11:41,480 Speaker 1: the provider insists it verifies patient information through multiple methods, 197 00:11:41,720 --> 00:11:45,160 Speaker 1: but it did not explain to TDA how or if 198 00:11:45,200 --> 00:11:49,720 Speaker 1: it checks images for signs of manipulation or distortion. Juniper 199 00:11:49,720 --> 00:11:54,120 Speaker 1: says TGA regulations mandate a minimum BMI and health related 200 00:11:54,120 --> 00:11:57,840 Speaker 1: weight condition in order to prescribe someone weight loss medications. 201 00:11:58,200 --> 00:12:02,360 Speaker 1: Body mass index or BMI is a traditional diagnostic tool 202 00:12:02,600 --> 00:12:06,120 Speaker 1: used to measure obesity. While its relevance and accuracy have 203 00:12:06,240 --> 00:12:10,199 Speaker 1: been called into question, BMI is still widely used by 204 00:12:10,200 --> 00:12:14,360 Speaker 1: healthcare providers across the board today. Juniper also told us 205 00:12:14,400 --> 00:12:17,880 Speaker 1: if a practitioner is uncertain about a patient's true BMI, 206 00:12:18,040 --> 00:12:21,440 Speaker 1: they have several options available to them, including converting a 207 00:12:21,480 --> 00:12:24,520 Speaker 1: phone consult to a video call, requesting a patient to 208 00:12:24,559 --> 00:12:27,720 Speaker 1: have their weight verified at a local GP clinical pharmacy, 209 00:12:28,040 --> 00:12:31,319 Speaker 1: or they can decline to prescribe medication to a patient. 210 00:12:32,000 --> 00:12:35,320 Speaker 1: That being said, Juniper did not provide any further detail 211 00:12:35,440 --> 00:12:38,000 Speaker 1: to the Daily OS on the frequency with which these 212 00:12:38,080 --> 00:12:43,880 Speaker 1: channels are or aren't being utilized. Sarah was prescribed weight 213 00:12:43,880 --> 00:12:46,959 Speaker 1: loss medication through Juniper when she was twenty four. 214 00:12:47,679 --> 00:12:52,160 Speaker 6: I just kind of became really fixated on how much 215 00:12:52,520 --> 00:12:55,320 Speaker 6: weight I was losing. So I was weighing my stylef 216 00:12:55,480 --> 00:12:58,840 Speaker 6: like two or three times a day, and it really 217 00:12:58,880 --> 00:13:02,480 Speaker 6: turned into a bit more of probably an eating disorder. 218 00:13:02,720 --> 00:13:05,960 Speaker 1: When she wanted to cancel her subscription, she said, Juniper's 219 00:13:05,960 --> 00:13:09,400 Speaker 1: follow up marketing made it really hard to walk away. 220 00:13:09,640 --> 00:13:12,719 Speaker 1: The provider sends regular emails and text messages to its 221 00:13:12,760 --> 00:13:17,000 Speaker 1: future and former patients with limited time offers and discount 222 00:13:17,000 --> 00:13:20,200 Speaker 1: codes to encourage them to either start using Juniper or 223 00:13:20,320 --> 00:13:21,199 Speaker 1: come back to it. 224 00:13:21,440 --> 00:13:23,400 Speaker 6: I work in marketing, so I was like, you know, 225 00:13:23,480 --> 00:13:26,600 Speaker 6: they're really really playing to your weaknesses here. I still 226 00:13:26,640 --> 00:13:30,240 Speaker 6: get targeted with their ads insanely. It's all very on 227 00:13:30,280 --> 00:13:31,040 Speaker 6: the nose for. 228 00:13:31,080 --> 00:13:34,880 Speaker 1: Me if you're already in a vulnerable spot. Sarah thinks 229 00:13:35,000 --> 00:13:38,960 Speaker 1: Juniper's approach to marketing could be detrimental to some patients. 230 00:13:39,440 --> 00:13:43,560 Speaker 1: This includes a Juniper Facebook ad showing what looks like 231 00:13:43,679 --> 00:13:46,560 Speaker 1: a real conversation between two Facebook users. 232 00:13:47,200 --> 00:13:51,800 Speaker 10: One says, anyone actually saving money since starting medical weight loss? 233 00:13:52,040 --> 00:13:54,640 Speaker 10: I am spending so much less on food. 234 00:13:55,120 --> 00:13:59,280 Speaker 3: In reply, another commenter says my monthly takeaway bill was 235 00:13:59,520 --> 00:14:02,640 Speaker 3: more than I'm saving money. 236 00:14:02,960 --> 00:14:07,240 Speaker 1: We asked Juniper about this Facebook ad, including whether it 237 00:14:07,320 --> 00:14:11,240 Speaker 1: was a real conversation between two users and why it 238 00:14:11,400 --> 00:14:14,920 Speaker 1: chose to promote saving money on food as a benefit 239 00:14:15,080 --> 00:14:19,400 Speaker 1: of weight loss medication. In a statement to TDA, Juniper 240 00:14:19,520 --> 00:14:23,479 Speaker 1: defended the ad, which it said, quote depicts an exchange 241 00:14:23,480 --> 00:14:26,920 Speaker 1: which was inspired by real conversations between members of the 242 00:14:27,000 --> 00:14:31,120 Speaker 1: Juniper online community. To protect the privacy of those members, 243 00:14:31,200 --> 00:14:34,280 Speaker 1: it said, we did not use their actual words or names, 244 00:14:34,640 --> 00:14:39,080 Speaker 1: but instead reflected their expressed sentiments in a paraphrased manner. 245 00:14:39,840 --> 00:14:43,120 Speaker 1: The platform describes saving money on food as a quote 246 00:14:43,360 --> 00:14:48,640 Speaker 1: genuine benefit experienced by Juniper's patients and a legitimate angle 247 00:14:48,760 --> 00:14:53,080 Speaker 1: to canvas in Juniper's messaging. The provider's comments did not 248 00:14:53,240 --> 00:14:56,720 Speaker 1: clarify whether the Juniper's marketing strategy is in alignment with 249 00:14:56,760 --> 00:14:59,280 Speaker 1: the latest harm minimization advice from. 250 00:14:59,120 --> 00:15:00,480 Speaker 3: Eating disorder ex experts. 251 00:15:01,520 --> 00:15:06,480 Speaker 1: It raises questions about Juniper's overall marketing strategy, including how 252 00:15:06,480 --> 00:15:11,440 Speaker 1: it engages with prospective customers. For example, anyone can enter 253 00:15:11,480 --> 00:15:15,800 Speaker 1: their details in Juniper's initial online screening questionnaire, so to 254 00:15:15,840 --> 00:15:20,360 Speaker 1: find out more, I took the quiz myself. Now I'm 255 00:15:20,400 --> 00:15:23,680 Speaker 1: someone who is in a quote unquote healthy bear my range, 256 00:15:23,760 --> 00:15:27,720 Speaker 1: and after completing the questionnaire, I was told great news, 257 00:15:28,080 --> 00:15:31,440 Speaker 1: I could lose ten kilos in four months with Juniper's 258 00:15:31,480 --> 00:15:35,200 Speaker 1: weight reset program. With this news, I was shown a 259 00:15:35,240 --> 00:15:39,840 Speaker 1: personalized graph with my projected weight loss trajectory. To go 260 00:15:39,880 --> 00:15:42,960 Speaker 1: any further, I'd need to speak to a Juniper practitioner, 261 00:15:43,440 --> 00:15:47,440 Speaker 1: and that would involve paying a refundable deposit. I left 262 00:15:47,480 --> 00:15:50,120 Speaker 1: it there for a few weeks, but after several follow 263 00:15:50,200 --> 00:15:53,960 Speaker 1: up emails, text messages, promotional offers encouraging me to take 264 00:15:54,000 --> 00:15:56,800 Speaker 1: the next step, I eventually paid a deposit and booked 265 00:15:56,800 --> 00:15:59,760 Speaker 1: in a phone consult From there, a Juniper nurse told 266 00:15:59,800 --> 00:16:03,680 Speaker 1: me that I was below the provider's minimum BEMI threshold 267 00:16:04,280 --> 00:16:09,360 Speaker 1: and was never actually eligible for treatment from the graph, 268 00:16:09,440 --> 00:16:12,640 Speaker 1: I was shown to the promotional emails and texts that 269 00:16:12,720 --> 00:16:17,040 Speaker 1: I received afterwards. Eating disorder experts worn this type of 270 00:16:17,080 --> 00:16:22,800 Speaker 1: promotion can be highly triggering and exacerbate feelings of body dissatisfaction. 271 00:16:23,720 --> 00:16:27,720 Speaker 1: So why does Juniper continue to heavily market its weight 272 00:16:27,760 --> 00:16:31,760 Speaker 1: loss program to patients who are within a healthy BMI range, 273 00:16:32,200 --> 00:16:35,520 Speaker 1: who it knows it can't prescribe medication to. 274 00:16:36,240 --> 00:16:39,000 Speaker 3: We asked the provider about this directly. 275 00:16:39,560 --> 00:16:43,160 Speaker 9: It said, we accept tda's concerns in relation to this 276 00:16:43,200 --> 00:16:45,720 Speaker 9: specific graph and are in the process of amending it 277 00:16:45,880 --> 00:16:48,480 Speaker 9: so that it does not display an initial weight which 278 00:16:48,480 --> 00:16:50,720 Speaker 9: falls within a healthy BMI range. 279 00:16:51,160 --> 00:16:55,080 Speaker 1: Kate is a healthcare professional and an ex Juniper employee 280 00:16:55,120 --> 00:16:59,040 Speaker 1: who shares the concerns raised by people like Sarah and McKenzie. 281 00:16:59,280 --> 00:17:02,240 Speaker 10: A lot of folks was placed on meeting KPIs for 282 00:17:02,400 --> 00:17:07,199 Speaker 10: prescribing ozempic and eventually munjaro. One nurse practitioner was prescribing 283 00:17:07,280 --> 00:17:11,000 Speaker 10: one patient ozempic or munjaro every thirty seconds within their 284 00:17:11,000 --> 00:17:13,760 Speaker 10: designated shift, which is hardly enough time to ask the 285 00:17:13,800 --> 00:17:18,760 Speaker 10: required screening questions. It felt misaligned with providing quality patient 286 00:17:18,800 --> 00:17:19,840 Speaker 10: care in a safe way. 287 00:17:20,240 --> 00:17:23,200 Speaker 1: Kate says, as ozepic became more talked about in media 288 00:17:23,200 --> 00:17:27,119 Speaker 1: and pop culture, Juniper customers started coming forward with concerns 289 00:17:27,160 --> 00:17:28,280 Speaker 1: about side effects. 290 00:17:28,520 --> 00:17:30,840 Speaker 10: We had a lot of scared customers reaching out and 291 00:17:31,000 --> 00:17:33,800 Speaker 10: information fed back to them by staff that I feel 292 00:17:33,920 --> 00:17:37,000 Speaker 10: was deceptive or not the whole truth. We also had 293 00:17:37,040 --> 00:17:40,600 Speaker 10: dietitians encouraging calorie counting, which concerned me greatly. 294 00:17:40,800 --> 00:17:45,800 Speaker 1: Staff concerns were dismissed, she claims. Kate also alleges workers 295 00:17:45,800 --> 00:17:50,280 Speaker 1: were discouraged from sharing information with community gps about patients 296 00:17:50,400 --> 00:17:54,120 Speaker 1: they may have had long standing relationships with, and says 297 00:17:54,160 --> 00:17:57,320 Speaker 1: the company cut ties with external health care providers who 298 00:17:57,400 --> 00:17:59,720 Speaker 1: voiced their concerns about patient care. 299 00:18:00,040 --> 00:18:02,800 Speaker 10: Plethora of issues that were coming through won't being addressed. 300 00:18:02,960 --> 00:18:07,440 Speaker 1: Kate claims staff were inundated with daily reports from patients 301 00:18:07,480 --> 00:18:11,080 Speaker 1: about mental health concerns and eating disorders, the scale of 302 00:18:11,119 --> 00:18:16,800 Speaker 1: which was downplayed by Eucalyptus, the company behind Juniper. She says, However, 303 00:18:16,920 --> 00:18:22,439 Speaker 1: Eucalyptus called this suggestion wildly inaccurate. It argues all clinicians 304 00:18:22,480 --> 00:18:26,560 Speaker 1: at Eucalyptus are well equipped to handle all patient concerns 305 00:18:27,440 --> 00:18:30,320 Speaker 1: in many instances, Kate said high risk cases were being 306 00:18:30,400 --> 00:18:34,439 Speaker 1: handled by pharmacists and general nurse practitioners who didn't have 307 00:18:34,520 --> 00:18:38,199 Speaker 1: the training and qualifications to do so. The company has 308 00:18:38,240 --> 00:18:42,320 Speaker 1: defended the capabilities of its staff to TDA, Although current 309 00:18:42,400 --> 00:18:46,720 Speaker 1: practices at Eucalyptus might not fully reflect the processes that 310 00:18:46,840 --> 00:18:51,200 Speaker 1: were in place when Kate worked there, Juniper's clinical director, 311 00:18:51,359 --> 00:18:53,200 Speaker 1: Doctor Matt Vickers. 312 00:18:52,640 --> 00:18:57,080 Speaker 9: Said nurse practitioners are specialist nurses have typically practiced for 313 00:18:57,080 --> 00:18:58,560 Speaker 9: at least ten to fifteen years. 314 00:18:59,000 --> 00:19:02,320 Speaker 1: These providers are accredited by the Nursing Board of Australia, 315 00:19:02,600 --> 00:19:05,879 Speaker 1: which permits them to prescribe any medications which fall within 316 00:19:05,960 --> 00:19:10,600 Speaker 1: their scope of practice. Doctor Vickers said Eucalyptus nurse practitioners 317 00:19:10,680 --> 00:19:14,280 Speaker 1: are required to undertake additional training when they're hired to 318 00:19:14,480 --> 00:19:19,399 Speaker 1: ensure they are adequately experienced in weight management prescribing. During 319 00:19:19,440 --> 00:19:23,640 Speaker 1: her time at Eucalyptus, Kate also alleges that vulnerable patients 320 00:19:23,760 --> 00:19:26,000 Speaker 1: did not receive prompt follow up care. 321 00:19:26,400 --> 00:19:29,160 Speaker 10: We had one concerned mother email us about her son 322 00:19:29,359 --> 00:19:32,120 Speaker 10: as he had a history of suicidal ideation and he'd 323 00:19:32,119 --> 00:19:35,640 Speaker 10: been able to purchase multiple quantities of ozambics somehow through 324 00:19:35,640 --> 00:19:39,400 Speaker 10: our service. She was worried he would overdose on his medication. 325 00:19:40,119 --> 00:19:42,000 Speaker 10: I was told not to engage with the mother as 326 00:19:42,040 --> 00:19:44,399 Speaker 10: she was not a customer, and instead reach out to 327 00:19:44,440 --> 00:19:44,840 Speaker 10: the sun. 328 00:19:45,320 --> 00:19:48,719 Speaker 1: She described instances where staff were discouraged from escalating an 329 00:19:48,720 --> 00:19:52,959 Speaker 1: issue to emergency services, or an instance when staff reached 330 00:19:53,000 --> 00:19:56,080 Speaker 1: out to a patient on their personal phone to conduct 331 00:19:56,119 --> 00:19:58,600 Speaker 1: an after hours welfare check themselves. 332 00:19:58,760 --> 00:20:01,119 Speaker 10: I was given very little a sistance or support to 333 00:20:01,160 --> 00:20:03,080 Speaker 10: deal with these situations in a safe way. 334 00:20:03,400 --> 00:20:07,479 Speaker 1: Doctor Matt Vickers strongly rejects these allegations and said the 335 00:20:07,520 --> 00:20:11,639 Speaker 1: company has clear internal benchmarks which are regularly audited to 336 00:20:11,800 --> 00:20:15,280 Speaker 1: ensure prompt follow up for all patient concerns, with the 337 00:20:15,320 --> 00:20:21,720 Speaker 1: most serious inquiries requiring the fastest response. On the last episode, 338 00:20:21,760 --> 00:20:25,840 Speaker 1: we spoke about GLP ones Wegovi and Munjaro, which were 339 00:20:25,880 --> 00:20:29,480 Speaker 1: developed in response to a global shortage of ozepic, a 340 00:20:29,560 --> 00:20:34,560 Speaker 1: medication originally developed for type two diabetes management. During that shortage, 341 00:20:34,640 --> 00:20:37,600 Speaker 1: Kate claims Junipus stockpiled ozepic supplies. 342 00:20:38,119 --> 00:20:41,760 Speaker 10: Kate says this was openly bragged about a company wide meetings. 343 00:20:42,040 --> 00:20:45,840 Speaker 1: At the time, the Therapeutic Goods Administration advised prescribers not 344 00:20:46,080 --> 00:20:49,520 Speaker 1: to start new patients on ozepic, with supplies to be 345 00:20:49,600 --> 00:20:52,840 Speaker 1: conserved for type two diabetes patients who have no other 346 00:20:52,920 --> 00:20:57,919 Speaker 1: treatment options. According to the latest TGA update, ozepic supply 347 00:20:58,080 --> 00:21:01,960 Speaker 1: issues are expected to continue new throughout twenty twenty five. 348 00:21:02,480 --> 00:21:07,560 Speaker 1: Juniper rejects claims it hoarded ozempic supplies and said the company. 349 00:21:07,240 --> 00:21:10,320 Speaker 9: Did not stockpile semaglue Tarde, but worked with a network 350 00:21:10,320 --> 00:21:13,760 Speaker 9: of pharmacies to maintain continuity of care for its patients. 351 00:21:13,960 --> 00:21:17,720 Speaker 1: Kate's o Zeenpic stockpiling allegation relates to a time before 352 00:21:17,760 --> 00:21:22,439 Speaker 1: the advent of popular alternatives like WEGOVY and Munjaro. Australian 353 00:21:22,480 --> 00:21:25,920 Speaker 1: Medical Association Chair of Public Health, doctor Michael Bonning says 354 00:21:25,960 --> 00:21:29,360 Speaker 1: these newer GLP ones have eased some of the pressure 355 00:21:29,400 --> 00:21:30,800 Speaker 1: on supply chains and. 356 00:21:30,800 --> 00:21:34,520 Speaker 5: Doctors prescribers have felt a bit more comfortable using that 357 00:21:34,720 --> 00:21:37,280 Speaker 5: for making sure that they're not ending up with people 358 00:21:37,440 --> 00:21:40,240 Speaker 5: or diabetics who are missing out on what is a 359 00:21:40,280 --> 00:21:42,080 Speaker 5: real blockbuster drug for diabetes. 360 00:21:42,720 --> 00:21:47,440 Speaker 1: While the ozepic shortage presented challenges for prescribers everywhere, Juniper's 361 00:21:47,440 --> 00:21:52,199 Speaker 1: treatment program now centers around wegov and Munjaro treatments. It 362 00:21:52,320 --> 00:21:56,159 Speaker 1: says its partner pharmacies currently have in stock and. 363 00:21:56,200 --> 00:21:59,920 Speaker 3: Available next time. 364 00:22:00,000 --> 00:22:04,480 Speaker 1: I'm on the final installment of Investigating Ozmpic. How has 365 00:22:04,520 --> 00:22:08,000 Speaker 1: the popularization of weight loss medication impacted the way young 366 00:22:08,040 --> 00:22:11,639 Speaker 1: people think about themselves health and body image. 367 00:22:11,800 --> 00:22:14,080 Speaker 10: A lot of people look up to these celebrities, especially 368 00:22:14,160 --> 00:22:14,760 Speaker 10: young women. 369 00:22:15,160 --> 00:22:17,800 Speaker 2: I think that means that a lot of young people 370 00:22:17,800 --> 00:22:20,439 Speaker 2: will think that when you're skinny, you're healthy. 371 00:22:20,880 --> 00:22:25,439 Speaker 1: How have these medications shifted conversations around obesity treatments and 372 00:22:25,640 --> 00:22:26,480 Speaker 1: diet culture. 373 00:22:26,800 --> 00:22:30,040 Speaker 2: If you take this drug, you are frowned on for 374 00:22:30,160 --> 00:22:33,520 Speaker 2: cheating and stealing it from diabetics. If you don't take 375 00:22:33,560 --> 00:22:37,359 Speaker 2: this drug, then you're frowned on for not taking the 376 00:22:37,400 --> 00:22:39,600 Speaker 2: options that are available. So I feel like it's a 377 00:22:39,640 --> 00:22:41,440 Speaker 2: situation where you can't win. 378 00:22:42,040 --> 00:22:45,480 Speaker 1: If this episode raised any issues or concerns for you, 379 00:22:45,560 --> 00:22:48,800 Speaker 1: help is available twenty four to seven through Lifeline on 380 00:22:48,920 --> 00:22:52,280 Speaker 1: thirteen eleven fourteen. For eating to sort of support, you 381 00:22:52,280 --> 00:22:56,600 Speaker 1: can contact the Butterfly Foundation on one eight hundred eedy hope, 382 00:22:56,880 --> 00:23:03,320 Speaker 1: that's one eight hundred double three four to six se. 383 00:23:07,960 --> 00:23:10,280 Speaker 3: My name is Lily Maddon and I'm a proud Arunda 384 00:23:10,480 --> 00:23:13,080 Speaker 3: Banjelung Calcuttin woman from Gadighl country. 385 00:23:13,880 --> 00:23:17,040 Speaker 8: The Daily oz acknowledges that this podcast is recorded on 386 00:23:17,080 --> 00:23:19,560 Speaker 8: the lands of the Gadighl people and pays respect to 387 00:23:19,640 --> 00:23:22,280 Speaker 8: all Aboriginal and torrest Rate island and nations. 388 00:23:22,600 --> 00:23:25,520 Speaker 3: We pay our respects to the first peoples of these countries, 389 00:23:25,680 --> 00:23:26,840 Speaker 3: both past and present.